Overview
Noninfectious jejunitis refers to inflammation of the jejunum not caused by infectious agents, often seen in autoimmune or inflammatory conditions affecting the small bowel. [Not directly addressed in provided abstracts]Diagnosis
Clinical presentation includes abdominal pain, malabsorption, and weight loss.
Endoscopy with biopsy is essential for histopathological confirmation.
Imaging studies (e.g., CT, MRI) may help rule out other causes but are not diagnostic alone.
Serological tests for autoimmune markers may be supportive but are not definitive. [Not directly addressed in provided abstracts]Management
First-line treatments: Corticosteroids are often used to control inflammation. Specific dosing details are not provided in the abstracts.
Adjunctive therapies: Immunosuppressive agents such as azathioprine or methotrexate may be considered in refractory cases. [Not directly addressed in provided abstracts]
Repository corticotropin gel injection: May serve as a complementary treatment option in some cases, though its efficacy specifically for jejunitis is not established in the provided abstracts. 1Special Populations
Pregnancy: Specific management strategies for noninfectious jejunitis in pregnant women are not detailed in the provided abstracts. [Not directly addressed in provided abstracts]
Pediatrics: No specific guidelines or studies addressing pediatric cases are mentioned. [Not directly addressed in provided abstracts]
Elderly: Considerations for elderly patients are not covered in the abstracts. [Not directly addressed in provided abstracts]
Comorbidities: Management adjustments for patients with comorbidities are not discussed in the provided sources. [Not directly addressed in provided abstracts]Key Recommendations
Use corticosteroids as first-line therapy for managing inflammation in noninfectious jejunitis. (Evidence: Expert opinion [Not directly addressed in provided abstracts])
Consider immunosuppressive agents for refractory cases, though specific dosing and efficacy data are lacking for jejunitis specifically. (Evidence: Expert opinion [Not directly addressed in provided abstracts])
Repository corticotropin gel injection may be considered as an adjunctive treatment, though its role in jejunitis is not substantiated by the provided evidence. (Evidence: Weak 1)References
1 Anesi SD, Chang PY, Maleki A, Manhapra A, Look-Why S, Asgari S et al.. Effects of Subcutaneous Repository Corticotropin Gel Injection on Regulatory T Cell Population in Noninfectious Retinal Vasculitis. Ocular immunology and inflammation 2023. link